sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma (Q40618753)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 6, 2003

Language	Label	Description	Also known as
English	sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma	scientific article published on November 6, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

sFlt-1 gene therapy of follicular thyroid carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma (English)

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

0 references

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

author name string

Caisheng Ye

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Chong Feng

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Shenming Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Nancy Huang

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Xiaoning Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Yongjie Lin

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mengfeng Li

8

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kent Z. Q. Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605010

30 March 2024

language of work or name

0 references

publication date

6 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

full work available at URL

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

145

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

817-822

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Clinical translation of angiogenesis inhibitors

2

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Vascular endothelial growth factor is a secreted angiogenic mitogen

3

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

4

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Growth factor signaling by receptor tyrosine kinases

5

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

VEGF receptor signaling and endothelial function.

6

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

7

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Human endothelial cell growth factors derived from thyroid anaplastic cell carcinoma

8

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms

9

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma

10

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation

11

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

12

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Angiogenesis in follicular tumors of the thyroid

14

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene

15

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo

16

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

17

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

18

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

19

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

20

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

22

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

23

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.

24

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

26

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.

27

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

29

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Assays for angiogenesis: A review

31

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors

32

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Suramin is a Potent Inhibitor of Vascular Endothelial Growth Factor. A Contribution to the Molecular Basis of its Antiangiogenic Action

33

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

35

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma

36

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin

37

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

38

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Adenoviral vector-mediated gene transfer for human gene therapy

39

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Progress toward vector design for hematopoietic stem cell gene therapy

40

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

New agents for the treatment of renal cell carcinoma

41

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

VEGF-Trap: a VEGF blocker with potent antitumor effects

43

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Combined effects of angiostatin and ionizing radiation in antitumour therapy

46

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.

47

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

48

1 reference

10.1210/EN.2003-1106

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Identifiers

10.1210/EN.2003-1106

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40618753&oldid=2116549392"